Catalyst Wire Dossier Catalyst Wire Dossier

ACEMg

magnesium-based compound · Keep Hearing, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACEMg, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: ACEMg Hearing Preservation, Tinnitus and Hyperacusis Relief [NA]

See pricing